Page last updated: 2024-08-18

1,3-ditolylguanidine and Brain Injuries

1,3-ditolylguanidine has been researched along with Brain Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abate, C; Berardi, F; Moritz, C; Peri, F1
De La Cruz-López, F; Flores, G; Garcés-Ramírez, L; González-Elizalde, K; Jaramillo-Loranca, BE; Luna Ramírez, C; Morales-Dionisio, O; Munguía Rosales, AA; Vargas Hernández, G; Zamudio, S1

Other Studies

2 other study(ies) available for 1,3-ditolylguanidine and Brain Injuries

ArticleYear
Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries.
    Neuroscience letters, 2015, Mar-30, Volume: 591

    Topics: Animals; Animals, Genetically Modified; Brain Injuries; Cell Movement; Embryo, Nonmammalian; Guanidines; Microglia; Microscopy, Confocal; Piperidines; Receptors, sigma; Tetrahydronaphthalenes; Zebrafish

2015
The sigma agonist 1,3-di-o-tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats.
    Synapse (New York, N.Y.), 2015, Volume: 69, Issue:4

    Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Behavior, Animal; Brain Injuries; Exploratory Behavior; Guanidines; Hippocampus; Male; Motor Activity; Prepulse Inhibition; Rats; Rats, Sprague-Dawley; Reflex, Startle; Silver Staining

2015